ChiCTR2400094740 版本V1.0 版本创建时间2024/12/26 16:24:52 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400094740 

最近更新日期:

Date of Last Refreshed on:

2024-12-26 16:24:45 

注册时间:

Date of Registration:

2024-12-26 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

膀胱癌患者心理痛苦与益处发现的影响因素及发展轨迹研究

Public title:

Influencing factors and developmental trajectories of psychological distress and benefit finding among bladder cancer patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

膀胱癌患者心理痛苦与益处发现的影响因素及发展轨迹研究

Scientific title:

Influencing factors and developmental trajectories of psychological distress and benefit finding among bladder cancer patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

康宴庆 

研究负责人:

吕爱莉 

Applicant:

Yanqing Kang 

Study leader:

Aili Lv 

申请注册联系人电话:

Applicant telephone:

+86 184 3504 8578

研究负责人电话:

Study leader's
telephone:

+86 137 0920 9696

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yq1336200942@163.com

研究负责人电子邮件:

Study leader's E-mail:

aili@mail.xjtu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

陕西省西安市雁塔区雁塔西路76号

研究负责人通讯地址:

陕西省西安市雁塔区雁塔西路76号

Applicant address:

No. 76, Yanta West Road, Yanta District, Xi'an City, Shaanxi Province, China

Study leader's address:

No. 76, Yanta West Road, Yanta District, Xi'an City, Shaanxi Province, China

申请注册联系人邮政编码:

Applicant postcode:

710061

研究负责人邮政编码:

Study leader's postcode:

710061

申请人所在单位:

西安交通大学

Applicant's institution:

Xi'an Jiaotong University

研究负责人所在单位:

西安交通大学/西安交通大学第一附属医院

Affiliation of the Leader:

Xi'an Jiaotong University/ The First Affiliated Hospital of Xi'an Jiaotong University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2024伦审医研字第(228)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

西安交通大学医学院第一附属医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of the First Affiliated Hospital of Xi 'an Jiaotong University Medical College

伦理委员会批准日期:

Date of approved by ethic committee:

2024-12-20 00:00:00

伦理委员会联系人:

白玲

Contact Name of the ethic committee:

Ling Bai

伦理委员会联系地址:

陕西省西安市雁塔西路277号

Contact Address of the ethic committee:

No. 277, West Yanta Road, Xi'an, Shaanxi Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 29 8532 3473

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

西安交通大学第一附属医院

Primary sponsor:

The First Affiliated Hospital of Xi'an Jiaotong University

研究实施负责(组长)单位地址:

陕西省西安市雁塔区雁塔西路76号

Primary sponsor's address:

No. 76, West Yanta Road, Xi'an, Shaanxi Province, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

陕西

市(区县):

西安

Country:

China

Province:

Shannxi

City:

Xi'an

单位(医院):

西安交通大学

具体地址:

陕西省西安市雁塔区雁塔西路277号

Institution
hospital:

Xi'an Jiaotong University

Address:

No. 277, Yanta West Road, Yanta District, Xi'an City, Shaanxi Province, China

经费或物资来源:

Source(s) of funding:

None

研究疾病:

膀胱癌  

Target disease:

Bladder cancer

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

了解新入膀胱癌患者疾病过程中心理痛苦与益处发现的现状及影响因素。通过追踪新入膀胱癌患者术后6个月内心理痛苦与益处发现的发展轨迹及相互关系,进一步揭示患者术后6个月内的心理变化过程。  

Objectives of Study:

To understand the current status and factors influencing psychological distress and benefit discovery during the disease process in newly admitted bladder cancer patients. To further reveal the process of psychological change in newly admitted bladder cancer patients during the 6 months after surgery by tracking the trajectory and interrelationship between psychological distress and benefit discovery during the 6 months after surgery.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1)病理诊断符合膀胱癌的新入患者; 2)年龄≥18岁; 3)知晓自身疾病诊断和病情; 4)知情同意、自愿参加者。

Inclusion criteria

1) Newly admitted patients with a pathological diagnosis consistent with bladder cancer; 2) Age >= 18 years; 3) Knowledge of their disease diagnosis and condition; 4) Agree to sign an informed consent form and voluntarily participate in this study.

排除标准:

1)意识、神志不清晰者; 2)无法用语言进行交流者; 3)有严重精神病病史者; 4)病情危重、有生命危险者; 5)伴有恶病质、全身感染或心脏与肝脏等重大疾病。

Exclusion criteria:

1) Those who are not conscious or lucid; 2) Those who are unable to communicate verbally; 3) Those with a history of severe mental illness; 4) Those with critical and life-threatening conditions; 5) With malignant disease, systemic infection, or major diseases of the heart and liver.

研究实施时间:

Study execute time:

From 2024-11-30 00:00:00 To 2025-12-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-02-10 00:00:00 To 2025-12-30 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

213

Group:

Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

陕西 

市(区县):

西安 

Country:

China

Province:

Shaanxi

City:

Xi'an

单位(医院):

西安交通大学第一附属医院 

单位级别:

三甲 

Institution
hospital:

The First Affiliated Hospital of Xi'an Jiaotong University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

一般资料与临床资料

指标类型:

次要指标

Outcome:

General and clinical information

Type:

Secondary indicator

测量时间点:

基线

测量方法:

问卷调查法

Measure time point of outcome:

Baseline

Measure method:

questionnaire

指标中文名:

心理痛苦温度计

指标类型:

主要指标

Outcome:

Distress Thermometer, DT

Type:

Primary indicator

测量时间点:

基线,术后1,3,6月

测量方法:

问卷调查法

Measure time point of outcome:

Baseline, 1,3,6 months postoperatively

Measure method:

questionnaire

指标中文名:

益处发现评定量表

指标类型:

主要指标

Outcome:

Benefit Finding Scale, BFS

Type:

Primary indicator

测量时间点:

基线,术后1,3,6月

测量方法:

问卷调查法

Measure time point of outcome:

Baseline, 1,3,6 months postoperatively

Measure method:

questionnaire

指标中文名:

医学应对方式问卷

指标类型:

次要指标

Outcome:

Medical Coping Modes Questionnaire, MCMQ

Type:

Secondary indicator

测量时间点:

基线

测量方法:

问卷调查法

Measure time point of outcome:

Baseline

Measure method:

questionnaire

指标中文名:

社会支持评定量表

指标类型:

次要指标

Outcome:

Social Support Rating Scale, SSRS

Type:

Secondary indicator

测量时间点:

基线

测量方法:

问卷调查法

Measure time point of outcome:

Baseline

Measure method:

questionnaire

指标中文名:

简易疾病感知问卷

指标类型:

次要指标

Outcome:

Brief Illness Perception Questionnaire, BIPQ

Type:

Secondary indicator

测量时间点:

基线

测量方法:

问卷调查法

Measure time point of outcome:

Baseline

Measure method:

questionnaire

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

通过问卷收集数据,密封保留原始问卷2年以上。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data were collected through questionnaires, and the original questionnaires were kept sealed for more than 2 years.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2024-12-26 16:24:45